Ona Kinduryte Schorling | Vice President, Global Medical Safety
Lundbeck

Ona Kinduryte Schorling (MD, MSc in Pharmaceutical Medicine) is a seasoned pharmaceutical executive with over 20 years of experience in pharmaceutical industry across a diverse range of therapeutic areas. Currently serving as the Vice President of Global Medical Safety at Lundbeck, Ona leads a team of patient safety professionals responsibe for safety evidence generation, safety profile characterization and risk minimisation strategies for investigational compounds and marketed products in the field of neuroscience.

With a strong background in pharmacovigilance, clinical development and risk management, Ona has a proven track record of implementing effective safety strategies to ensure the well-being of patients worldwide. Her in-depth knowledge of global safety regulations, enterprise mindset, forward-thinking approach and her ability to navigate and drive results in highly complex environments make her a valuable asset in the field of drug safety.

Ona is passionate about driving innovation in Patient Safety & Pharmacovigilance and is committed to fostering collaboration and knowledge-sharing through industry networking groups. As a track lead and a panelist at the World Drug Safety Congress Europe 2025, Ona Kinduryte Schorling will contribute with her insights on barriers and enablers for adoption of digital technologies and benefit-risk frameworks to advance innovation in safety science.